Status:
COMPLETED
A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective, observational, multi-center study will evaluate the use of biological agents (e.g. RoActemra/Actemra \[tocilizumab\]) in monotherapy in patients with rheumatoid arthritis. Data fro...
Eligibility Criteria
Inclusion
- Adult patients, \>/= 18 years of age
- Diagnosis of rheumatoid arthritis
- Currently receiving a biologic agent in monotherapy (corticosteroids and/or non-steroidal anti-inflammatory drugs are permitted)
Exclusion
- Concomitant treatment with disease-modifying anti-rheumatic drugs (DMARDs) for the treatment of rheumatoid arthritis
- Patients that have started their current monotherapy before 01/01/2009
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01834807
Start Date
April 1 2013
End Date
August 1 2013
Last Update
November 2 2016
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalst, Belgium, 9300
2
Brussels, Belgium, 1070
3
Edegem, Belgium, 2650
4
Genk, Belgium, 3600